Comparison of three rapid diagnostic tests for Plasmodium falciparum diagnosis in Ghana

Author:

Kayode Tolulope Adeyemi,Addo Agyapong Kofi,Addison Thomas Kwame,Tweneboah Austine,Afriyie Stephen Opoku,Abbas Dawood Ackom,Seth Ayesha,Badu-Tawiah Abraham K.,Badu Kingsley,Koepfli Cristian

Abstract

Abstract Background Accurate diagnosis and timely treatment are crucial in combating malaria. Methods A total of 449 samples were screened for Plasmodium falciparum infection by expert microscopy, qPCR, and three RDTs, namely Rapigen Biocredit Malaria Ag Pf (detecting HRP2 and pLDH on separate bands), Abbott NxTek Eliminate Malaria Ag Pf (detecting HRP2), and SD Bioline Malaria Ag Pf (detecting HRP2). hrp2/3 deletion typing was done by digital PCR. Results 45.7% (205/449) individuals tested positive by qPCR for P. falciparum with a mean parasite density of 12.5 parasites/μL. Using qPCR as reference, the sensitivity of microscopy was 28.3% (58/205), the Biocredit RDT was 52.2% (107/205), the NxTek RDT was 49.3% (101/205), and the Bioline RDT was 39.5% (81/205). When only samples with densities > 20 parasites/μL were included (n = 89), sensitivity of 62.9% (56/89) by microscopy, 88.8% (79/89) by Biocredit, 88.8% (79/89) by NxTek, and 78.7% (70/89) by Bioline were obtained. All three RDTs demonstrated specificities > 95%. The limits of detection (95% probability that a sample tested positive) was 4393 parasites/μL (microscopy), 56 parasites/μL (Biocredit, considering either HRP2 or pLDH), 84 parasites/μL (NxTek), and 331 parasites/μL (Bioline). None of the three qPCR-confirmed P. falciparum positive samples, identified solely through the pLDH target, or eight samples negative for all RDTs but qPCR-positive at densities > 20 parasites/µL carried hrp2/3 deletions. Conclusion The Biocredit and NxTek RDTs demonstrated comparable diagnostic efficacies. All three RDTs performed better than microscopy.

Funder

NIH

University of Notre Dame

Bill and Melinda Gates Foundation

Publisher

Springer Science and Business Media LLC

Reference54 articles.

1. WHO. World malaria report 2022. Geneva: World Health Organization; 2023. [Internet]. 2023 [cited 2024 Jun 26]. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023

2. WHO. Global Malaria program. Diagnostic Testing. [Internet]. Geneva: World Health Organization; 2021 [cited 2024 Jun 26]. https://www.who.int/teams/global-malaria-programme/case-management/diagnosis#:~:text=Prompt%20malaria%20diagnosis%20either%20by,and%20for%20strong%20malaria%20surveillance.

3. Niyukuri D, Sinzinkayo D, Troth EV, Oduma CO, Barengayabo M, Ndereyimana M, et al. Performance of highly sensitive and conventional rapid diagnostic tests for clinical and subclinical Plasmodium falciparum infections, and hrp2/3 deletion status in Burundi. PLoS Global Public Health. 2022;2: e0000828.

4. WHO. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 8 (2016–2018) [Internet]. Geneva: World Health Organization; 2018 [cited 2024 Jun 27]. https://www.who.int/publications/i/item/9789241514965

5. Houzé S, Boly MD, Le Bras J, Deloron P, Faucher JF. Pf HRP2 and Pf LDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malar J. 2009;8:211.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3